Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Pretreatment With Recombinant Human Thyrotropin (rhTSH) for the Effect on Thyroid Size and Function, and for the Effect of Radioiodine Treatment in Patients With Nodular Goiter. Prospective, Randomized Double-blinded Trials.

NCT00145366 is registered in ClinicalTrials.gov with Odense University Hospital as lead sponsor.

NCT NCT00145366
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00145366 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Pretreatment With Recombinant Human Thyrotropin (rhTSH) for the Effect on Thyroid Size and Function, and for the Effect of Radioiodine Treatment in Patients With Nodular Goiter. Prospective, Randomized Double-blinded Trials.
Lead sponsor
Odense University Hospital
Phase
Phase 2
Overall status
Completed
Start date
April 30, 2002
Completion date
July 31, 2005
Enrollment
110
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

benign nontoxic and toxic goiter, graves' disease